Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Associate

Emily Josef

Goodwin Procter

main

Josef Emily

Goodwin Associate Emily Josef, from San Francisco, practices in firm’s Business Law Department and Debt Finance

Emily Josef

Areas of Practice

Credentials

Education

JD2019

Bachelor of Science in Public Health2016

Admissions

Bars

Related Content

BlueHalo To Be Acquired By AeroVironment In $4.1 Billion All-Stock Transaction

Novo Holdings to Acquire Catalent in All-Cash $16.5 Billion Transaction

Goodwin Advises Thoma Bravo on $1.8 Billion Acquisition of NextGen Healthcare, Inc.

AirLife Completes Acquisition of Avanos Medical’s Respiratory Health Business

Thoma Bravo To Acquire NextGen Healthcare

SunMed Acquires Vyaire Medical’s Respiratory and Anesthesia Consumables Business

Avanos Medical Announces Sale of Respiratory Health Business to SunMed Group Holdings

Blueprint Medicines Announces Transformative $1.25 Billion Strategic Financing Collaborations with Sixth Street and Royalty Pharma

Technology M&A

Debt Finance